"This is the first clinical trial to demonstrate that semaglutide may improve liver fibrosis in patients with advanced MASH, including those with compensated cirrhosis," said Rohit Loomba, MD, senior author of the study, gastroenterologist and hepatologist at UC San Diego Health and chief of the Division of Gastroenterology and Hepatology at UC San Diego School of Medicine
doi:10.1073/pnas.1607571113 Nicolson GL, Rosenblatt S, de Mattos GF, et al
This dual-pronged approach addresses both internal and external routes of detoxification
KPV has been investigated in NF-B, epithelial, and animal colitis models, although these studies do not prove that KLOW treats inflammatory conditions in humans
Peptides should not replace diagnosis, rehabilitation, progressive loading, mobility work, strength training, or appropriate medical care
The cosmetic endpoint you're chasing requires sustained dermal exposure over weeks, not peak plasma concentration in the first 90 minutes